FIELD: medicine.
SUBSTANCE: what is presented is using pentacyclic triterpenoid miliacine as an agent to reduce systemic pathological endotoxinemia accompanying the salmonella infection.
EFFECT: pre-administration of miliacine has provided reducing blood endotoxins in the infected animals and the production of the inflammation mediators IL-6, IL-17, gamma-INF, but increasing the production of the proinflammatory cytokine IL-10; death of the infected animals has been decreased.
2 dwg
Title | Year | Author | Number |
---|---|---|---|
ANTIMUTAGENIC AGENT | 2019 |
|
RU2698204C1 |
METHOD OF PROTECTING POST-VACCINATION IMMUNITY TO TETANUS ANATOXIN AGAINST METHOTREXATE-INDUCED DEPRESSION | 2008 |
|
RU2394577C1 |
MEANS FOR SELECTIVE EFFECT ON BIOFILM FORMATION BY MICROORGANISMS | 2016 |
|
RU2646488C2 |
METHOD FOR DIAGNOSTICS OF LATENT DISEASES BASING ON SYSTEMIC ENDOTOXAMIA INDICES | 2015 |
|
RU2609763C1 |
AGENT LIMITING LYMPHOTOXIN EFFECT OF METHOTREXATE | 2007 |
|
RU2337693C1 |
METHOD FOR COMPLEX CORRECTION OF NON-SCARRING ALOPECIA IN EXPERIMENT | 2023 |
|
RU2821779C1 |
METHOD FOR REDUCING GEMOTOXIC ACTION OF BENZENE ON AN ORGANISM | 2017 |
|
RU2724891C2 |
AGENT ENHANCING IMMUNOGENIC PROPERTY OF TETANUS ANATOXIN | 2003 |
|
RU2244548C1 |
MEDICATION INCREASING NON-SPECIFIC RESISTANCE OF ORGANISM TO BACTERIAL ENDOTOXINS | 2007 |
|
RU2351351C1 |
METHOD FOR TREATMENT OF UBEITIS OF OBSCURE AND VIRAL ETIOLOGY | 2005 |
|
RU2301672C1 |
Authors
Dates
2015-10-10—Published
2014-05-07—Filed